drugset / Trial / NCT06525584

Ketamine Infusion as a Method of Cerebral Protection in Children

NCT06525584 ↗

Recruiting 196 enrolled Kemerovo State Medical University
RandomizedParallel-groupSingle-blindPrevention

Summary

The study is devoted to the use of ketamine infusion in a subanesthetic dose in the postoperative period in children after surgical correction of congenital heart defects in children.

Timeline

Start
2023-11-05
Primary completion
2025-12
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.1 mg/kg —
Subject Ketamine Small molecule 0.3 mg/kg —

Indications